|
Real-time Estimate
Cboe BZX
09:55:44 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 7.150 USD | -1.65% |
|
-5.94% | -30.74% |
| Market Cap | 262M 225M 211M 193M 363M 25.04B 364M 2.49B 975M 12.62B 984M 963M 41.76B | P/E 2026 * |
-1.82x | P/E 2027 * | -2.03x |
|---|---|---|---|---|---|
| Enterprise Value | 232M 199M 186M 171M 322M 22.16B 323M 2.21B 863M 11.17B 871M 852M 36.96B | EV / Sales 2026 * |
12.2x | EV / Sales 2027 * | -0.85x |
| Free-Float |
85.77% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Entrada Therapeutics, Inc.
| 22-12-20 | Nipte winst op Wall Street | |
| 22-12-20 | Wall Street licht hoger | |
| 22-12-20 | Wall Street richting rode opening |
| 1 day | -1.44% | ||
| 1 week | -5.94% | ||
| Current month | +4.86% | ||
| 1 month | +22.13% | ||
| 3 months | +4.40% | ||
| 6 months | -39.04% | ||
| Current year | -30.74% |
| 1 week | 6.8 |  | 7.67 |
| 1 month | 5.78 | | 7.97 |
| Current year | 5.63 | | 16.45 |
| 1 year | 5.02 | | 16.45 |
| 3 years | 4.93 | | 21.79 |
| 5 years | 4.93 | | 36.85 |
| 10 years | 4.93 | | 36.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 50 | 2017-07-31 |
Kory Wentworth
DFI | Director of Finance/CFO | 47 | 2020-10-31 |
Nathan Dowden
PSD | President | 56 | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
BRD | Director/Board Member | 50 | 2017-07-31 |
Kush Parmar
CHM | Chairman | 44 | 2020-11-30 |
Peter Kim
BRD | Director/Board Member | 67 | 2020-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/26/26 | MPM BioImpact LLC
| Sell | Company | -14,569 | 0.0374% | |
| 8/26/26 | MPM BioImpact LLC
| Sell | Company | -14,569 | 0.0374% | |
| 8/10/26 | 5AM Venture Management LLC
| Sell | Company | -92,444 | 0.2374% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.65% | -5.94% | +26.02% | -57.21% | 262M | |
| +3.31% | -3.70% | +61.03% | +103.64% | 70.64B | |
| -0.71% | -0.18% | +49.42% | +91.74% | 66.11B | |
| -6.71% | -13.64% | -1.23% | -16.58% | 27.98B | |
| -3.00% | -4.09% | -10.63% | +457.91% | 26.51B | |
| +0.30% | -0.69% | +63.18% | +11.93% | 26.44B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 20.4B | |
| +0.14% | +0.33% | +33.83% | -17.95% | 20.17B | |
| -1.91% | -4.37% | +13.33% | +531.29% | 15.99B | |
| -1.00% | +1.56% | +44.92% | +147.63% | 13.69B | |
| Average | -0.99% | +0.45% | +54.93% | +167.27% | 28.82B | |
| Weighted average by Cap. | -0.33% | +0.65% | +55.33% | +153.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 19.05M 16.35M 15.31M 14.02M 26.41M 1.82B 26.49M 181M 70.87M 917M 71.53M 69.98M 3.04B | 20M 17.17M 16.07M 14.72M 27.73M 1.91B 27.81M 190M 74.41M 963M 75.1M 73.48M 3.19B |
| Net income | -170M -146M -137M -125M -236M -16.26B -237M -1.62B -633M -8.2B -639M -626M -27.13B | -191M -164M -154M -141M -265M -18.27B -266M -1.82B -712M -9.21B -718M -703M -30.48B |
| Net Debt | -30.12M -25.86M -24.21M -22.17M -41.76M -2.88B -41.88M -287M -112M -1.45B -113M -111M -4.8B | -279M -240M -224M -205M -387M -26.65B -388M -2.66B -1.04B -13.43B -1.05B -1.03B -44.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | US$7.170 | -1.38% | 8,049 |
| 26-08-27 | US$7.270 | +3.86% | 248,603 |
| 26-08-26 | US$7.000 | -8.14% | 229,319 |
| 26-08-25 | US$7.620 | +3.96% | 269,980 |
| 26-08-24 | US$7.330 | -3.17% | 184,249 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TRDA Stock
Select your edition
All financial news and data tailored to specific country editions
